Misplaced Pages

Vitamin C megadosage

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Consumption or injection of very large doses of vitamin C

Chemical structure of vitamin C
3D molecular model of vitamin C
Part of a series on
Alternative medicine
General information
Fringe medicine and science
Controversies
Classifications
Traditional medicine
Alternative diagnoses

Vitamin C megadosage is a term describing the consumption or injection of vitamin C (ascorbic acid) in doses well beyond the current United States Recommended Dietary Allowance of 90 milligrams per day, and often well beyond the tolerable upper intake level of 2,000 milligrams per day. There is no strong scientific evidence that vitamin C megadosage helps to cure or prevent cancer, the common cold, or some other medical conditions.

Historical advocates of vitamin C megadosage include Linus Pauling, who won the Nobel Prize in Chemistry in 1954. Pauling argued that because humans and other primates lack a functional form of L-gulonolactone oxidase, an enzyme required to make vitamin C that is functional in almost all other mammals, plants, insects, and other life forms, humans have developed a number of adaptations to cope with the relative deficiency. These adaptations, he argued, ultimately shortened lifespan but could be reversed or mitigated by supplementing humans with the hypothetical amount of vitamin C that would have been produced in the body if the enzyme were working.

Vitamin C megadoses are claimed by alternative medicine advocates including Matthias Rath and Patrick Holford to have preventive and curative effects on diseases such as cancer and AIDS, but scientific evidence does not support these claims. Some trials show some effect in combination with other therapies, but this does not imply vitamin C megadoses in themselves have any therapeutic effect.

Background

Vitamin C is an essential nutrient used in the production of collagen and other biomolecules, and for the prevention of scurvy. It is also an antioxidant, which has led to its endorsement by some researchers as a complementary therapy for improving quality of life. Certain animal species, including the haplorhine primates (which include humans), members of the Caviidae family of rodents (including guinea pigs and capybaras), most species of bats, many passerine birds, and about 96% of fish (the teleosts), cannot synthesize vitamin C internally and must therefore rely on external sources, typically obtained from food.

For humans, the World Health Organization recommends a daily intake of 45 mg/d of vitamin C for healthy adults, and 25–30 mg/d in infants.

Since its discovery, vitamin C has been considered almost a panacea by some, although this led to suspicions of it being overhyped by others. Vitamin C has long been promoted in alternative medicine as a treatment for the common cold, cancer, polio, and various other illnesses. The evidence for these claims is mixed. Since the 1930s, when it first became available in pure form, some physicians have experimented with higher-than-recommended vitamin C consumption or injection. Orthomolecular-based megadose recommendations for vitamin C are based mainly on theoretical speculation and observational studies, such as those published by Ferd R. Klenner from the 1940s through the 1970s. There is a strong advocacy movement for very high doses of vitamin C, yet there is an absence of large-scale, formal trials in the 10 to 200+ grams per day range.

The single repeatable side effect of oral megadose vitamin C is a mild laxative effect if the practitioner attempts to consume too much too quickly. In the United States and Canada, a tolerable upper intake level (UL) was set at 2,000 mg/day, citing this mild laxative effect as the reason for establishing the UL. However, the European Food Safety Authority (EFSA) reviewed the safety question in 2006 and reached the conclusion that there was not sufficient evidence to set a UL for vitamin C. The Japan National Institute of Health and Nutrition reviewed the same question in 2010 and also reached the conclusion that there was not sufficient evidence to set a UL.

About 70–90% of vitamin C is absorbed by the body when taken orally at normal levels (30–180 mg daily). Only about 50% is absorbed from daily doses of 1 gram (1,000 mg). Even oral administration of megadoses of 3g every four hours cannot raise blood concentration above 220 micromol/L.

Adverse effects

Although sometimes considered free of toxicity, there are known side effects from vitamin C intake, and it has been suggested that intravenous injections should require "a medical environment and trained professionals."

For example, a genetic condition that results in inadequate levels of the enzyme glucose-6-phosphate dehydrogenase (G6PD) can cause affected people to develop hemolytic anemia after using intravenous vitamin C treatment. The G6PD deficiency test is a common laboratory test.

Because oxalic acid is produced during metabolism of vitamin C, hyperoxaluria can be caused by intravenous administration of ascorbic acid. Vitamin C administration may also acidify the urine and could promote the precipitation of kidney stones or drugs in the urine.

Although vitamin C can be well tolerated at doses well above what government organizations recommend, adverse effects can occur at doses above 3 grams per day. The common "threshold" side effect of megadoses is diarrhea caused by oral consumption of vitamin C in such doses. Other possible adverse effects regardless of the mode of administration include increased oxalate excretion and kidney stones, increased uric acid excretion, systemic conditioning ("rebound scurvy"), preoxidant effects, iron overload, reduced absorption of vitamin B12 and copper, increased oxygen demand, and acid erosion of the teeth when chewing vitamin C tablets. In addition, one woman received a kidney transplant followed by high-dose vitamin C and died soon afterward as a result of calcium oxalate deposits that destroyed her new kidney. Her doctors concluded that high-dose vitamin C therapy should be avoided in patients with kidney failure.

Overdose

As discussed previously, vitamin C generally exhibits low toxicity. The LD50 (the dose that will kill 50% of a population) is generally accepted to be 11,900 milligrams (11.9 grams) per kilogram in rat populations. The American Association of Poison Control Centers has reported zero deaths from vitamin C toxicity in 2018.

Interactions

Pharmaceuticals designed to reduce stomach acid, such as the proton-pump inhibitors (PPIs), are among the most widely sold drugs in the world. One PPI, omeprazole (Prilosec), has been found to lower the bioavailability of vitamin C by 12% after 28 days of treatment, independent of dietary intake. The probable mechanism of vitamin C reduction, intragastric pH elevated into alkalinity, would apply to all other PPI drugs, though not necessarily to doses of PPIs low enough to keep the stomach slightly acidic. In another study, 40 mg/day of omeprazole lowered the fasting gastric vitamin C levels from 3.8 to 0.7 μg/mL. Aspirin may also inhibit the absorption of vitamin C.

Regulation

Regulations in most countries limit the claims regarding treatment of disease that can be placed on food and dietary-supplement product labels. For example, claims of therapeutic effect with respect to the treatment of any medical condition or disease are prohibited by the United States Food and Drug Administration even if the substance in question has gone through well-conducted clinical trials with positive outcomes. Claims are limited to "structure and function" phrasing (like "helps maintain a healthy immune system") and the following notice is mandatory on food and dietary-supplement product labels that make these types of health claims: "These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."

Research

Cancer

The use of vitamin C in high doses as a treatment for cancer was promoted by Linus Pauling, based on a 1976 study published with Ewan Cameron which reported intravenous vitamin C significantly increased lifespans of patients with advanced cancer. This trial was criticized by the National Cancer Institute for being designed poorly, and three subsequent trials conducted at the Mayo Clinic could not replicate the results.

Preliminary clinical trials in humans have shown that it is unlikely to be a "miracle pill" for cancer and more research is necessary before any definitive conclusions about efficacy can be reached. A 2010 review of 33 years of research on vitamin C to treat cancer stated "we have to conclude that we still do not know whether Vitamin C has any clinically significant antitumor activity. Nor do we know which histological types of cancers, if any, are susceptible to this agent. Finally, we don't know what the recommended dose of Vitamin C is, if there is indeed such a dose, that can produce an anti-tumor response." Recent studies show that vitamin C has the potential to be a potent anti-cancer agent when administered intravenously and in high doses (high-dose IVC), but these are primary research studies not confirmed by other researchers.

The American Cancer Society has stated, "Although high doses of vitamin C have been suggested as a cancer treatment, the available evidence from clinical trials has not shown any benefit."

Burns

One clinical trial used high intravenous doses of vitamin C (66 mg/kg/hour for 24 hours, for a total dose of around 110 grams) after severe burn injury, but despite being described as promising, it has not been replicated by independent institutions and thus is not a widely accepted treatment. Based on that study, the American Burn Association (ABA) considers high-dose ascorbic acid an option to be considered for adjuvant therapy in addition to the more accepted standard treatments.

Cardiac effects

Atrial fibrillation (AF) is a common cardiac rhythm disturbance associated with oxidative stress. Four meta-analyses have concluded that there is strong evidence that consuming 1–2 g/day of vitamin C before and after cardiac operations can decrease the risk of post-operative AF. However, five randomized studies did not find any such benefit in the United States, so that the benefit was restricted to less wealthy countries.

Exercise-induced bronchoconstriction

Exercise-induced bronchoconstriction (EIB) indicates acute narrowing of the airways as a result of vigorous exercise. EIB seems to be caused by the loss of water caused by increased ventilation, which may lead to the release of mediators such as histamine, prostaglandins, and leukotrienes, all of which cause bronchoconstriction. Vitamin C participates in the metabolism of these mediators and might thereby influence EIB. A meta-analysis showed that 0.5 to 2 g/day of vitamin C before exercise decreased EIB by half, but these findings were based on 3 trials of small groups, with one study being inconclusive, and all studies having 40 participants in total, and were not confirmed by any larger study.

Endothelial function

A 2014 meta-analysis showed a significant positive effect of vitamin C on endothelial function in people where this function was negatively affected by atherosclerosis, diabetes or heart failure. Endothelial function refers to how well the endothelium (the thin layer of cells lining the inside of blood vessels) works. This layer is responsible for maintaining healthy blood flow and proper blood pressure. Benefit was found of vitamin C in doses ranging from 0.5 to 4 g/day, whereas lower doses from 0.09 to 0.5 g/day were not effective. No effect on endothelial function was seen in healthy volunteers, including healthy smokers.

Common cold

Further information: Vitamin C and the common cold

A frequently cited meta-analysis calculated that various doses of vitamin C, all greater than 0.2 g, did not prevent the common cold in the general community, although 0.25 to 1 g/day of vitamin C halved the incidence of colds in people under heavy short-term physical stress. Another meta-analysis calculated that, in children, 1–2 g/day vitamin C shortened the duration of colds by 18%, and in adults 1–4 g/day vitamin C shortened the duration of colds by 8%. There is evidence of higher doses being more effective on common cold duration up to 6–8 g/day. The cited studies of larger daily doses of vitamin C do not take into account the fast excretion rate of vitamin C at gram-level doses, which makes it necessary to give the total daily amount in smaller, more frequent doses to maintain higher plasma levels.

COVID-19

While earlier, preliminary studies predicted promising results on high-dose vitamin C administration (intravenously) in COVID-19 patients, these results were not confirmed by later studies. Systematic reviews and meta‐analysis of randomized controlled trials of intravenous administration of high doses of vitamin C (such as 12 g, every 12 hours for 7 days) in mild, moderate, severe, and critically ill COVID-19 patients concluded that vitamin C administration did not influence disease severity or mortality in comparison with a control group who took placebo. Although there was benefit observed in some small studies, this benefit was no better than that of placebo; therefore, the usefulness of vitamin C administration in COVID-19 patients was not confirmed by large-scale randomized trials. Intravenous vitamin C administration was widely used in 2020 for treating critically ill COVID-19 patients in China, but 2024 meta-analysis of these studies found that vitamin C supplementation did not reduce death rates in COVID-19 patients compared to those receiving standard care, and total hospital stay was not decreased; however, the rate of adverse effects in patients who received vitamin C was the same as in control groups that did not receive vitamin C.

Sepsis

People in sepsis may have micronutrient deficiencies, including low levels of vitamin C. An intravenous intake of doses much higher than the RDA, such as 3 g/d or more, appears to be needed to maintain normal plasma concentrations in people with sepsis, as the body's demand for Vitamin C may increase significantly due to the heightened inflammatory response and oxidative stress. Sepsis mortality may be reduced with administration of intravenous vitamin C.

Gout

There is no good evidence that vitamin C is of benefit for treating or preventing gout and its use for this purpose is not recommended by the American College of Rheumatology.

Society and culture

Eearly proponents

The practice of vitamin C megadosage has been influenced by various social and cultural factors, such as the popularity of alternative medicine, the media coverage of scientific controversies, and the personal testimonies of celebrities and public figures, rather than scientific medial research. One of the most influential proponents of vitamin C megadosage was Linus Pauling, a renowned chemist and Nobel laureate. In 1954 he won the Prize for Chemistry. Eight years later he was awarded the Peace Prize for his opposition to weapons of mass destruction. Linus Pauling advocated for the use of vitamin C to prevent and treat various diseases, especially the common cold and cancer. Still, the arguments given in these books were not based on solid peer-reviewed medical research. Pauling published several books and articles on the topic, such as Vitamin C and the Common Cold (1970) and Vitamin C and Cancer (1979). These publications attracted a large public attention and stimulated a scientific debate. Pauling also claimed that he personally took up to 18 grams of vitamin C per day and attributed his longevity and health to this practice. Pauling's views were challenged by many mainstream medical experts, who argued that there was no convincing evidence to support his claims and that his methodology was flawed and biased. Pauling died of prostate cancer in 1994 at the age of 93.

Another prominent figure in the vitamin C megadosage movement was Matthias Rath, a German physician and researcher, who collaborated with Pauling in the 1980s and 1990s. Rath proposed that vitamin C and other micronutrients could prevent and cure cardiovascular diseases, AIDS, and cancer, by strengthening the immune system and inhibiting the spread of infections and tumors. Rath also founded the Rath Foundation, a non-profit organization that promotes his ideas and products, and the Dr. Rath Research Institute, a scientific facility that conducts research on micronutrients and health. Rath has been criticized by the medical community and the media for making unsubstantiated and misleading claims, for exploiting the AIDS epidemic in South Africa, and for opposing the use of antiretroviral drugs. Rath has also been involved in several legal disputes and controversies, such as suing the British Medical Journal for defamation, and being banned from selling his products in several countries.

Relative deficiency hypothesis

Linus Pauling's popular and influential 1986 book How to Live Longer and Feel Better advocated very high doses of vitamin C

Relative deficiency hypothesis is based on assumption that humans and other species, that cannot synthesize their own vitamin C, carry a mutated and ineffective form of the enzyme L-gulonolactone oxidase, the fourth and last step in the ascorbate-producing machinery. In the anthropoids lineage, this mutation likely occurred 40 to 25 million years ago. The three surviving enzymes continue to produce the precursors to vitamin C, but the absence of the fourth enzyme means the process is never completed, and the body ultimately disassembles the precursors.

In the 1960s, Linus Pauling, after contact with Irwin Stone, began actively promoting vitamin C as a means to greatly improve human health and resistance to disease. The Pauling's book How to Live Longer and Feel Better, first published in 1986, was a bestseller and advocated taking more than 10 grams per day orally, thus approaching the amounts released by the liver directly into the circulation in other mammals: an adult goat, a typical example of a vitamin C–producing animal, will manufacture more than 13000 mg of vitamin C per day in normal health and much more when stressed.

Matthias Rath, a German physician, who worked with and published two articles discussing the possible relationship between lipoprotein and vitamin C with Pauling. He is an active proponent and publicist for high-dose vitamin C. Pauling's and Rath's extended theory states that deaths from scurvy in humans during the Pleistocene, when vitamin C was scarce, selected for individuals who could repair arteries with a layer of cholesterol provided by lipoprotein(a), a lipoprotein found in vitamin C-deficient species.

Stone and Pauling believed that the optimum daily requirement of vitamin C is around 2,300 milligrams for a human requiring 2,500 kcal per day. For comparison, the FDA's recommended daily allowance of vitamin C is only 90 milligrams.

Public figure endorsement

Vitamin C megadosage has also been endorsed by some celebrities and public figures, who have shared their personal experiences and opinions on the subject. For example, the actor Steve McQueen, who was diagnosed with terminal mesothelioma in 1979, sought treatment from William Donald Kelley, a dentist and alternative medicine practitioner, who prescribed him a regimen of vitamin C injections, coffee enemas, and dietary supplements. McQueen claimed that his condition improved after following Kelley's protocol, but he died of a heart attack in 1980 after undergoing surgery in Mexico. The singer-songwriter John Lennon, who was a friend and admirer of Pauling, also reportedly took large doses of vitamin C and advocated for its benefits. Actress Gwyneth Paltrow, who is known for her lifestyle brand Goop which promotes various alternative health and wellness products and practices, has also expressed her support for vitamin C megadosage, stating that she takes up to 15 grams of vitamin C per day to boost her immunity and energy.

The public interest and awareness of vitamin C megadosage has been influenced by the media coverage of the scientific research and controversies on the topic, as well as the marketing and advertising of vitamin C products and services. The media has often portrayed vitamin C megadosage as a controversial, but potentially effective and harmless, alternative to conventional medicine, especially for the treatment of the common cold and cancer. The media has also reported on the personal stories and opinions of the advocates and critics of vitamin C megadosage, as well as the legal and ethical issues involved in the practice. The marketing and advertising of vitamin C products and services, such as supplements, injections, infusions, and creams, has also contributed to the popularity and demand of vitamin C megadosage, by emphasizing its purported benefits and safety, and by appealing to the consumers' emotions and values. However, some of these products and services may not be regulated or approved by the relevant authorities, and may not have sufficient evidence or quality to support their claims.

See also

References

  1. ^ Institute of Medicine (2000). "Vitamin C". Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: The National Academies Press. pp. 95–185. ISBN 978-0-309-06935-9. Archived from the original on 2 September 2017. Retrieved 1 September 2017.
  2. ^ "Vitamin C". American Cancer Society. Archived from the original on 24 April 2015. Retrieved 25 January 2013.
  3. ^ Barret Steven, MD (14 September 2014). "The Dark Side of Linus Pauling's Legacy". www.quackwatch.org. Archived from the original on 4 September 2018. Retrieved 18 December 2018.{{cite web}}: CS1 maint: multiple names: authors list (link)
  4. Bad Science, Ben Goldacre
  5. David Gorski Archived 19 August 2012 at the Wayback Machine, Science Based Medicine, 18 August 2008
  6. Gropper SS, Smith JL, Grodd JL (2004). Advanced Nutrition and Human Metabolism (4th ed.). Belmont, CA. US: Thomson Wadsworth. pp. 260–275.
  7. Yeom CH, Jung GC, Song KJ (2007). "Changes of terminal cancer patients' health-related quality of life after high dose vitamin C administration". J. Korean Med. Sci. 22 (1): 7–11. doi:10.3346/jkms.2007.22.1.7. PMC 2693571. PMID 17297243.
  8. ^ Pauling L (1970). "Evolution and the need for ascorbic acid". Proc. Natl. Acad. Sci. USA. 67 (4): 1643–1648. Bibcode:1970PNAS...67.1643P. doi:10.1073/pnas.67.4.1643. PMC 283405. PMID 5275366.
  9. Pollock JI, Mullin RJ (1987). "Vitamin C biosynthesis in prosimians: Evidence for the anthropoid affinity of Tarsius". American Journal of Physical Anthropology. 73 (1): 65–70. doi:10.1002/ajpa.1330730106. PMID 3113259.
  10. R. Eric Miller, Murray E. Fowler (31 July 2014). Fowler's Zoo and Wild Animal Medicine, Volume 8. Elsevier Health Sciences. p. 389. ISBN 9781455773992. Archived from the original on 28 September 2023. Retrieved 2 June 2016.
  11. Jenness R, Birney E, Ayaz K (1980). "Variation of l-gulonolactone oxidase activity in placental mammals". Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology. 67 (2): 195–204. doi:10.1016/0305-0491(80)90131-5.
  12. ^ Martinez del Rio C (July 1997). "Can passerines synthesize vitamin C?". The Auk. 114 (3): 513–16. doi:10.2307/4089257. JSTOR 4089257.
  13. Vitamin and mineral requirements in human nutrition (PDF) (2nd ed.). World Health Organization. 2004. p. 138. ISBN 978-9241546126. Archived (PDF) from the original on 1 July 2015. Retrieved 31 December 2014.
  14. Levy T (2011). Primal Panacea. MedFox Publishing. p. 352. ISBN 978-0983772804.
  15. Harri Hemilä (January 2006). "Do vitamins C and E affect respiratory infections?" (PDF). University of Helsinki. Archived from the original (PDF) on 4 August 2016. Retrieved 21 February 2007.
  16. "Vitamin C (Ascorbic Acid)". University of Maryland Medical Center. April 2002. Archived from the original on 31 December 2005. Retrieved 19 February 2007.
  17. "Tolerable Upper Intake Levels For Vitamins And Minerals" (PDF). European Food Safety Authority. 2006. Archived (PDF) from the original on March 16, 2016.
  18. Dietary Reference Intakes for Japanese 2010: Water-Soluble Vitamins Archived 14 September 2019 at the Wayback Machine Journal of Nutritional Science and Vitaminology 2013(59):S67-S82.
  19. "Office of Dietary Supplements - Vitamin C". ods.od.nih.gov. Archived from the original on 30 July 2017. Retrieved 26 February 2016.
  20. ^ Verrax J, Calderon PB (December 2008). "The controversial place of vitamin C in cancer treatment". Biochem. Pharmacol. 76 (12): 1644–52. doi:10.1016/j.bcp.2008.09.024. PMID 18938145.
  21. Rees DC, Kelsey H, Richards JD (March 1993). "Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency". BMJ. 306 (6881): 841–2. doi:10.1136/bmj.306.6881.841. PMC 1677333. PMID 8490379.
  22. Nankivell BJ, Murali KM (2008). "Renal failure from vitamin C after transplantation". The New England Journal of Medicine. 358 (4): e4. doi:10.1056/NEJMicm070984. PMID 18216350.
  23. "Safety (MSDS) data for ascorbic acid". Oxford University. 9 October 2005. Archived from the original on 9 February 2007. Retrieved 21 February 2007.
  24. "American Association of Poison Control Centers (AAPCC) - Annual Report". aapcc.org. Archived from the original on 19 December 2018. Retrieved 18 December 2018.
  25. E. B. Henry, A. Carswell, A. Wirz, V. Fyffe & K. E. L. Mccoll (September 2005). "Proton pump inhibitors reduce the bioavailability of dietary vitamin C". Alimentary Pharmacology and Therapeutics. 22 (6): 539–45. doi:10.1111/j.1365-2036.2005.02568.x. PMID 16167970. S2CID 23976667.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  26. C. Mowat, A. Carswell, A. Wirz, K.E. McColl (April 1999). "Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice". Gastroenterology. 116 (4): 813–22. doi:10.1016/s0016-5085(99)70064-8. PMID 10092303.
  27. Loh HS, Watters K, Wilson CW (1 November 1973). "The Effects of Aspirin on the Metabolic Availability of Ascorbic Acid in Human Beings". J Clin Pharmacol. 13 (11): 480–486. doi:10.1002/j.1552-4604.1973.tb00203.x. PMID 4490672. Archived from the original on 16 March 2007. Retrieved 31 July 2007.
  28. Basu TK (1982). "Vitamin C-aspirin interactions". Int J Vitam Nutr Res Suppl. 23: 83–90. PMID 6811490.
  29. "Dietary Supplement Health and Education Act of 1994". Food and Drug Administration. Archived from the original on 30 July 2015. Retrieved 16 December 2019.
  30. Cameron E, Pauling L (October 1976). "Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer". Proc. Natl. Acad. Sci. USA. 73 (10): 3685–3689. Bibcode:1976PNAS...73.3685C. doi:10.1073/pnas.73.10.3685. PMC 431183. PMID 1068480.
  31. ^ Cabanillas F (2010). "Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later?". Puerto Rico Health Sciences Journal. 29 (3): 215–7. PMID 20799507.
  32. Böttger F, Vallés-Martí A, Cahn L, Jimenez CR (2021). "High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer". Journal of Experimental & Clinical Cancer Research. 40 (1): 343. doi:10.1186/s13046-021-02134-y. PMC 8557029. PMID 34717701.
  33. "Intravenous High-Dose Vitamin C in Cancer Therapy - NCI". 24 January 2020.
  34. Berger MM (October 2006). "Antioxidant micronutrients in major trauma and burns: evidence and practice". Nutr Clin Pract. 21 (5): 438–49. doi:10.1177/0115426506021005438. PMID 16998143.
  35. Greenhalgh DG (2007). "Burn resuscitation". J Burn Care Res. 28 (4): 555–65. doi:10.1097/bcr.0b013e318093df01. PMID 17665515. S2CID 3683908.
  36. Pham TN, Cancio LC, Gibran NS (2008). "American Burn Association practice guidelines burn shock resuscitation". J Burn Care Res. 29 (1): 257–66. doi:10.1097/BCR.0b013e31815f3876. PMID 18182930. S2CID 3694150. Archived from the original on 24 September 2017. Retrieved 5 February 2024.
  37. Baker WL, Coleman CI (2016). "Meta-analysis of ascorbic acid for prevention of postoperative atrial fibrillation after cardiac surgery". American Journal of Health-System Pharmacy. 73 (24): 2056–2066. doi:10.2146/ajhp160066. PMID 27806938.
  38. Polymeropoulos E, Bagos P, Papadimitriou M, Rizos I, Patsouris E, Toumpoulis I (2016). "Vitamin C for the Prevention of Postoperative Atrial Fibrillation after Cardiac Surgery: A Meta-Analysis". Advanced Pharmaceutical Bulletin. 6 (2): 243–50. doi:10.15171/apb.2016.033. PMC 4961983. PMID 27478787.
  39. Hu X, Yuan L, Wang H, Li C, Cai J, Hu Y, Ma C (2017). "Efficacy and safety of vitamin C for atrial fibrillation after cardiac surgery: A meta-analysis with trial sequential analysis of randomized controlled trials". International Journal of Surgery. 37: 58–64. doi:10.1016/j.ijsu.2016.12.009. PMID 27956113.
  40. ^ Hemilä H, Suonsyrjä T (2017). "Vitamin C for preventing atrial fibrillation in high risk patients: A systematic review and meta-analysis". BMC Cardiovascular Disorders. 17 (1): 49. doi:10.1186/s12872-017-0478-5. PMC 5286679. PMID 28143406.
  41. Hemilä H (2017). "Publication bias in meta-analysis of ascorbic acid for postoperative atrial fibrillation". American Journal of Health-System Pharmacy. 74 (6): 372–373. doi:10.2146/ajhp160999. hdl:10138/312602. PMID 28274978.
  42. Hemilä H (2014). "The effect of vitamin C on bronchoconstriction and respiratory symptoms caused by exercise: A review and statistical analysis". Allergy, Asthma & Clinical Immunology. 10 (1): 58. doi:10.1186/1710-1492-10-58. PMC 4363347. PMID 25788952.
  43. Hemilä H (2013). "Vitamin C may alleviate exercise-induced bronchoconstriction: A meta-analysis". BMJ Open. 3 (6): e002416. doi:10.1136/bmjopen-2012-002416. PMC 3686214. PMID 23794586.
  44. ^ Ashor AW, Lara J, Mathers JC, Siervo M (July 2014). "Effect of vitamin C on endothelial function in health and disease: a systematic review and meta-analysis of randomised controlled trials". Atherosclerosis. 235 (1): 9–20. doi:10.1016/j.atherosclerosis.2014.04.004. PMID 24792921.
  45. ^ Zhou HL, Jiang XZ, Ventikos Y (2023). "Role of blood flow in endothelial functionality: a review". Front Cell Dev Biol. 11: 1259280. doi:10.3389/fcell.2023.1259280. PMC 10613523. PMID 37905167.
  46. ^ Hemilä H, Chalker E (2013). "Vitamin C for preventing and treating the common cold". Cochrane Database of Systematic Reviews. 2013 (1): CD000980. doi:10.1002/14651858.CD000980.pub4. PMC 1160577. PMID 23440782.
  47. Hemilä H (2017). "Vitamin C and Infections". Nutrients. 9 (4): 339. doi:10.3390/nu9040339. PMC 5409678. PMID 28353648.
  48. Hickey S, Roberts H (27 September 2005). "Misleading Information on the Properties of Vitamin C". PLOS Medicine. 2 (9): e307. doi:10.1371/journal.pmed.0020307. PMC 1236801. PMID 16173838.
  49. Zhao B, Ling Y, Li J, Peng Y, Huang J, Wang Y, Qu H, Gao Y, Li Y, Hu B, Lu S, Lu H, Zhang W, Mao E (February 2021). "Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study". Ann Palliat Med. 10 (2): 1599–1609. doi:10.21037/apm-20-1387. PMID 33222462.
  50. Zheng S, Chen Q, Jiang H, Guo C, Luo J, Li S, Wang H, Li H, Zheng X, Weng Z (2021). "No significant benefit of moderate-dose vitamin C on severe COVID-19 cases". Open Med (Wars). 16 (1): 1403–1414. doi:10.1515/med-2021-0361. PMC 8459914. PMID 34616916.
  51. Rawat D, Roy A, Maitra S, Gulati A, Khanna P, Baidya DK (2021). "Vitamin C and COVID-19 treatment: A systematic review and meta-analysis of randomized controlled trials". Diabetes Metab Syndr. 15 (6): 102324. doi:10.1016/j.dsx.2021.102324. PMC 8552785. PMID 34739908.
  52. Dresen E, Lee ZY, Hill A, Notz Q, Patel JJ, Stoppe C (February 2023). "History of scurvy and use of vitamin C in critical illness: A narrative review" (PDF). Nutr Clin Pract. 38 (1): 46–54. doi:10.1002/ncp.10914. PMID 36156315.
  53. Vollbracht C, Kraft K (2022). "Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C". Front Pharmacol. 13: 899198. doi:10.3389/fphar.2022.899198. PMC 9100929. PMID 35571085.
  54. Ao G, Li J, Yuan Y, Wang Y, Nasr B, Bao M, Gao M, Qi X (April 2022). "Intravenous vitamin C use and risk of severity and mortality in COVID-19: A systematic review and meta-analysis". Nutr Clin Pract. 37 (2): 274–281. doi:10.1002/ncp.10832. PMC 9088481. PMID 35148440.
  55. Kow CS, Hasan SS, Ramachandram DS (December 2023). "The effect of vitamin C on the risk of mortality in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials". Inflammopharmacology. 31 (6): 3357–3362. doi:10.1007/s10787-023-01200-5. PMC 10111321. PMID 37071316.
  56. ^ Xu C, Yi T, Tan S, Xu H, Hu Y, Ma J, Xu J (April 2023). "Association of Oral or Intravenous Vitamin C Supplementation with Mortality: A Systematic Review and Meta-Analysis". Nutrients. 15 (8): 1848. doi:10.3390/nu15081848. PMC 10146309. PMID 37111066.
  57. Shahbaz U, Fatima N, Basharat S, Bibi A, Yu X, Hussain MI, Nasrullah M (2022). "Role of vitamin C in preventing of COVID-19 infection, progression and severity". AIMS Microbiology. 8 (1): 108–124. doi:10.3934/microbiol.2022010. PMC 8995185. PMID 35496992.
  58. Rs N, Reddy MV, Batra S, Srivastava SK, Syal K (August 2022). "Vitamin C and its therapeutic potential in the management of COVID19". Clin Nutr ESPEN. 50: 8–14. doi:10.1016/j.clnesp.2022.05.026. PMC 9166267. PMID 35871955.
  59. Xu W, Wang P, Wan J, Tan Y, Liu Y, Chen Q, Zheng Y, Yu X, Fan S, Jorge Luis CD, Zhang Y (2024). "Effect of vitamin C supplementation on outcomes in patients with COVID-19: A systematic review and meta-analysis". Frontiers in Nutrition. 11. doi:10.3389/fnut.2024.1465670. PMC 11484096. PMID 39421622.
  60. Belsky JB, Wira CR, Jacob V, Sather JE, Lee PJ (December 2018). "A review of micronutrients in sepsis: the role of thiamine, L-carnitine, vitamin C, selenium and vitamin D". Nutrition Research Reviews. 31 (2): 281–90. doi:10.1017/S0954422418000124. PMID 29984680. S2CID 51599526.
  61. Langlois PL, Manzanares W, Adhikari NK, Lamontagne F, Stoppe C, Hill A, Heyland DK (March 2019). "Vitamin C Administration to the Critically Ill: A Systematic Review and Meta-Analysis". JPEN J Parenter Enteral Nutr. 43 (3): 335–346. doi:10.1002/jpen.1471. PMID 30452091.
  62. Liang B, Su J, Shao H, Chen H, Xie B (March 2023). "The outcome of IV vitamin C therapy in patients with sepsis or septic shock: a meta-analysis of randomized controlled trials". Crit Care. 27 (1): 109. doi:10.1186/s13054-023-04392-y. PMC 10012592. PMID 36915173.
  63. Berger MM, Oudemans-van Straaten HM (March 2015). "Vitamin C supplementation in the critically ill patient". Curr Opin Clin Nutr Metab Care. 18 (2): 193–201. doi:10.1097/MCO.0000000000000148. PMID 25635594. S2CID 37895257.
  64. Liang H, Mu Q, Sun W, Liu L, Qiu S, Xu Z, Cui Y, Yan Y, Sun T (2023). "Effect of intravenous vitamin C on adult septic patients: a systematic review and meta-analysis". Front Nutr. 10: 1211194. doi:10.3389/fnut.2023.1211194. PMC 10437115. PMID 37599680.
  65. FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, Gelber AC, Harrold LR, Khanna D, King C, Levy G, Libbey C, Mount D, Pillinger MH, Rosenthal A, Singh JA, Sims JE, Smith BJ, Wenger NS, Bae SS, Danve A, Khanna PP, Kim SC, Lenert A, Poon S, Qasim A, Sehra ST, Sharma TS, Toprover M, Turgunbaev M, Zeng L, Zhang MA, Turner AS, Neogi T (June 2020). "2020 American College of Rheumatology Guideline for the Management of Gout". Arthritis Care Res (Hoboken). 72 (6): 744–760. doi:10.1002/acr.24180. PMC 10563586. PMID 32391934.
  66. Hemilä H (1997). "Vitamin C supplementation and the common cold--was Linus Pauling right or wrong?". International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Fur Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition. 67 (5): 329–335. PMID 9350474. Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  67. ^ Schlueter AK, Johnston CS (2011). "Vitamin C: Overview and Update". Journal of Evidence-Based Complementary & Alternative Medicine. 16 (1): 49–57. doi:10.1177/1533210110392951. S2CID 72568141. Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  68. "The Dark Side of Linus Pauling's Legacy | Quackwatch". 14 September 2014. Archived from the original on 29 September 2018. Retrieved 1 February 2024.
  69. "Pauling Recommendation". 21 October 2014. Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  70. "My Love Affair with Vitamin C". Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  71. "Biographical Overview". 12 March 2019. Archived from the original on 1 October 2023. Retrieved 1 February 2024.
  72. Donaldson MS (2004). "Nutrition and cancer: A review of the evidence for an anti-cancer diet". Nutrition Journal. 3 (1): 19. doi:10.1186/1475-2891-3-19. PMC 526387. PMID 15496224.
  73. Carr A (2017). "Symposium on Vitamin C, 15th September 2017; Part of the Linus Pauling Institute's 9th International Conference on Diet and Optimum Health". Antioxidants. 6 (4): 94. doi:10.3390/antiox6040094. PMC 5745504. PMID 29160838.
  74. ^ Chen Z, Huang Y, Cao D, Qiu S, Chen B, Li J, Bao Y, Wei Q, Han P, Liu L (2022). "Vitamin C Intake and Cancers: An Umbrella Review". Frontiers in Nutrition. 8. doi:10.3389/fnut.2021.812394. PMC 8812486. PMID 35127793.
  75. Frei B, Lawson S (2008). "Vitamin C and cancer revisited". Proceedings of the National Academy of Sciences. 105 (32): 11037–11038. Bibcode:2008PNAS..10511037F. doi:10.1073/pnas.0806433105. PMC 2516245. PMID 18682554.
  76. ^ Pan S, Frenking G (2021). "A Critical Look at Linus Pauling's Influence on the Understanding of Chemical Bonding". Molecules. 26 (15): 4695. doi:10.3390/molecules26154695. PMC 8348226. PMID 34361846.
  77. Davenport DA (1996). "The Many Lives of Linus Pauling: A Review of Reviews". Journal of Chemical Education. 73 (9): A210. Bibcode:1996JChEd..73A.210D. doi:10.1021/ed073pA210. Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  78. Hargittai I (2010). "Linus Pauling's quest for the structure of proteins". Structural Chemistry. 21 (1): 1–7. doi:10.1007/s11224-009-9565-2. Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  79. Hemilä H, Chalker E (2023). "Vitamin C reduces the severity of common colds: A meta-analysis". BMC Public Health. 23 (1): 2468. doi:10.1186/s12889-023-17229-8. PMC 10712193. PMID 38082300.
  80. Douglas RM, Hemilä H (2005). "Vitamin C for Preventing and Treating the Common Cold". PLOS Medicine. 2 (6): e168. doi:10.1371/journal.pmed.0020168. PMC 1160577. PMID 15971944.
  81. "Vitamin C and the common cold" (PDF). Archived (PDF) from the original on 1 February 2024. Retrieved 6 February 2024.
  82. "20th Anniversary: Linus Pauling's Death". 19 August 2014. Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  83. "Linus Pauling and the Riddle of Aging - Richard P. Huemer, M.D." Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  84. Rich A (1994). "Linus Pauling (1901-1994)" (PDF). Nature. 371 (6495): 285. Bibcode:1994Natur.371..285R. doi:10.1038/371285a0. PMID 8090196. Archived (PDF) from the original on 16 June 2023. Retrieved 1 February 2024.
  85. "Dr. Rath's Biography". Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  86. "Research". Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  87. ^ Colvin CJ, Robins S (2009). "Social Movements and HIV/AIDS in South Africa". HIV/AIDS in South Africa 25 Years on. Springer. pp. 155–164. doi:10.1007/978-1-4419-0306-8_11. ISBN 978-1-4419-0305-1. Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  88. "Unknown". TheGuardian.com.
  89. "Promoter of vitamins for AIDS calls off lawsuits". ProQuest. Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  90. Padayatty SJ, Levine M (8 September 2016). "Vitamin C: the known and the unknown and Goldilocks". Oral Diseases. 22 (6): 463–493. doi:10.1111/odi.12446. PMC 4959991. PMID 26808119.
  91. "My Love Affair with Vitamin C" (PDF). Archived (PDF) from the original on 29 May 2015. Retrieved 24 May 2015.
  92. Pauling L (1 May 2006). How to Live Longer and Feel Better. Oregon State University Press. ISBN 978-0870710964.
  93. . ISBN 978-0716717751. {{cite book}}: Missing or empty |title= (help)
  94. Rath M, Pauling L (1990). "Immunological evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion of the hypoascorbemic guinea pig". Proc Natl Acad Sci USA. 87 (23): 9388–9390. Bibcode:1990PNAS...87.9388R. doi:10.1073/pnas.87.23.9388. PMC 55170. PMID 2147514.
  95. Rath M, Pauling L (1990). "Hypothesis: lipoprotein(a) is a surrogate for ascorbate". Proc. Natl. Acad. Sci. USA. 87 (16): 6204–6207. Bibcode:1990PNAS...87.6204R. doi:10.1073/pnas.87.16.6204. PMC 54501. PMID 2143582.
  96. Rath M, Pauling L (1992). "A unified theory of human cardiovascular disease leading the way to the abolition of this disease as a cause for human mortality" (PDF). Journal of Orthomolecular Medicine. 7 (1): 5–15. Archived (PDF) from the original on 26 December 2018. Retrieved 28 December 2008.
  97. Stone I (1972). The Healing Factor: Vitamin C Against Disease. Grosset and Dunlap. ISBN 978-0-448-11693-8. OCLC 3967737. Archived from the original on 1 November 2019. Retrieved 2 June 2009.
  98. "Court case shines spotlight on South Africas AIDS policy" (PDF). Archived (PDF) from the original on 1 February 2024. Retrieved 6 February 2024.
  99. "Faith Guides Steve McQueen Through Mesothelioma Battle". Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  100. Pulos R (2020). "COVID-19 crisis memes, rhetorical arena theory and multimodality". Journal of Science Communication. 19 (7): A01. doi:10.22323/2.19070201. Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  101. Caulfield T (5 May 2015). Is Gwyneth Paltrow Wrong About Everything?: How the Famous Sell Us Elixirs of Health, Beauty & Happiness. Beacon Press. ISBN 978-0-8070-5748-3. Archived from the original on 1 February 2024. Retrieved 1 February 2024.
  102. Hickey S, Saul AW (23 October 2015). Vitamin C: The Real Story: The Remarkable and Controversial Healing Factor. Basic Health Publications. ISBN 978-1-59120-223-3. Archived from the original on 1 February 2024. Retrieved 1 February 2024.

External links

Vitamins (A11)
Fat
soluble
A
D
E
K
Water
soluble
B
C
Combinations
Linus Pauling
Publications
Concepts
Founded
Related
Unproven and disproven cancer treatments
Alternative health systems
Diet-based
Electromagnetic and energy-based
Hybrid
Plant and fungus-based
Physical procedures
Mental and spiritual
Synthetic chemicals and other substances
Related
Categories: